Company: NIVFW
Filing Date: 2025-08-21
Form Type: DRS
Source: 0001213900-25-079301
Chunk: 4

Company: NewGenIvf Group Ltd
Filing Date: 2025-08-21
Form: DRS
Chunk 4
---
 accordance with the Panel’s extension, the Company has already made progress on its compliance
plan, including carrying out a 1-for-20 reverse stock split of its issued and unissued shares which was effected on February 11, 2025.
The effect of the reverse stock split was to consolidate every 20 issued and unissued share into one share. On February 27, 2025, the
Company received a notification letter from Nasdaq, indicating that the closing bid price of the Company’s securities had been at
$1.00 per share or greater for 10 consecutive business days from February 11, 2025 to February 26, 2025, and the Company had regained
compliance with the minimum bid price rule. In addition, on February 27, 2025, the Company received a confirmation from Nasdaq that its
application to transfer its listing to the Nasdaq Capital Market had been approved and that the Company’s securities would be transferred
to the Nasdaq Capital Market at the opening of business on February 28, 2025.

The information contained or incorporated in this prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus or any sale of our securities.

Investing in our securities being offered pursuant to this prospectus involves a high degree of risk, including the risk of losing your entire investment. See “ Risk Factors” starting on page 27 to read about the factors you should consider before buying the Ordinary Shares.

Neither the Securities and Exchange Commission, or the SEC, nor any state or other foreign securities commission has approved nor disapproved these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

|                                         |     | PER CLASS A    
 ORDINARY SHARE |     | APPROXIMATE TOTAL |
|:----------------------------------------|:----|:---------------|:----|:------------------|
| Public offering price                   |     | $              |     | $                 |
| Placement agent commission(1)           |     | $              |     | $                 |
| Proceeds to the Company before expenses |     | $              |     | $                 |

We have engaged D.
Boral Capital LLC as our exclusive placement agent to use its reasonable best efforts to solicit offers to purchase the Class A
Ordinary Shares and Warrants offered by this prospectus. The placement agent has no obligation to buy any of the securities from us
or to arrange for the purchase or